Provides relative to opioid treatment programs. (gov sig)

Senate Bill 26 repeals two provisions of Louisiana Revised Statutes Title 40 that currently govern the licensing and expansion of opioid treatment programs in the state. Specifically, the bill eliminates R.S. 40:2116(B)(5) and R.S. 40:2159, which together establish a facility need review requirement that the Louisiana Department of Health must complete before licensing new or additional opioid treatment programs. Under present law, the Department of Health cannot issue a behavioral health services provider license for an opioid treatment program unless the department first determines that there is an actual need for such a program in the specific geographic location where it would operate, using criteria and processes established by departmental regulation. Senate Bill 26 removes these prerequisites entirely, eliminating the need review process and allowing the department to license opioid treatment programs without conducting a geographic need analysis.

The practical effect of this legislation is to remove regulatory barriers to the establishment and expansion of opioid treatment programs throughout Louisiana. Currently, entrepreneurs, healthcare providers, and organizations seeking to open new opioid treatment facilities or expand existing ones must first convince the Department of Health that their geographic area lacks sufficient treatment capacity. By eliminating this requirement, the bill allows private entities and organizations to establish opioid treatment programs more freely, subject only to whatever other licensing and operational requirements remain in statute. This change particularly benefits individuals seeking addiction treatment in underserved areas, as the removal of need review barriers may enable faster development of treatment infrastructure in communities where access is currently limited or absent. The Department of Health will no longer expend resources conducting need assessments or maintaining the regulatory framework for those assessments.

Senate Bill 26 operates within Louisiana's regulatory framework for behavioral health services and substance abuse treatment licensing, which is codified in Title 40 of the Louisiana Revised Statutes. The facility need review process that the bill repeals has long been a feature of healthcare regulation in Louisiana, where the state has used similar mechanisms to control healthcare infrastructure development across various service categories. By eliminating need review specifically for opioid treatment programs, the legislature is making a policy choice to deregulate market entry in this particular healthcare sector while maintaining other licensing and operational standards. The bill becomes effective immediately upon the governor's signature or upon the lapse of time for gubernatorial action, ensuring rapid implementation once enacted.